Concepedia

David Steadman

DS

Statistics

Publications

18

Citations

690

H-Index

15

Active since

1998

Affiliations

University College London(Current)

Alzheimer’s Research UK

The Francis Crick Institute

Centre for Human Genetics

Institute of Structural and Molecular Biology

David Steadman is an author at University College London specializing in life sciences, biochemistry, and enzyme inhibition.

ORCID

Publications per year

1998–2021

18

Publications

18

Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells

Jonathan Powell, Filipa Mota, David Steadman et al. · Journal of Medicinal Chemistry · 2018 · 82 citations · Full text

, , +17

Structure of Human Thymidylate Synthase Suggests Advantages of Chemotherapy with Noncompetitive Inhibitors

Jason Phan, David Steadman, Sangita Koli et al. · Journal of Biological Chemistry · 2001 · 77 citations · Full text

, , +16

DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1

David Steadman · Nucleic Acids Research · 2000 · 74 citations · Full text

, , +13

α,α′-Dihydroxyketone formation using aromatic and heteroaromatic aldehydes with evolved transketolase enzymes

James L. Galman, David Steadman, Sarah Bacon et al. · Chemical Communications · 2010 · 52 citations

, , +14

Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling

Elliott D. Bayle, Fredrik Svensson, Benjamin N. Atkinson et al. · Journal of Medicinal Chemistry · 2021 · 48 citations · Full text

, , +7

1–5 of 18